Cure Pharmaceutical is a specialty pharmaceutical and bioscience company developing drug formulation and delivery technologies.
Cure Pharmaceutical has raised $625K in total funding. The most recent round was Debt Financing. The last funding was announced in September 2022.
Cure Pharmaceutical is headquartered in Oxnard, United States.
Cure Pharmaceutical is a specialty pharmaceutical and bioscience company developing drug formulation and delivery technologies.
Cure Pharmaceutical is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cure Pharmaceutical — Funding & Investors." VCBacked, September 14, 2022, https://www.vcbacked.co/company/cure-pharmaceutical. Accessed August 14, 2026.
VCBacked. (2022). Cure Pharmaceutical — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cure-pharmaceutical
{{cite web |title=Cure Pharmaceutical — Funding & Investors |url=https://www.vcbacked.co/company/cure-pharmaceutical |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated